ADMA BIOLOGICS INC - C

ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek, SC

18 Jan 2022 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Adopts Limited Duration Stockholder Rights Plan

21 Dec 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Provides Update on Global Intellectual Property Portfolio

09 Dec 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of Directors

17 Nov 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myrtle Beach, SC

16 Nov 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments

10 Nov 2021 15:01:01 By Nasdaq GlobeNewswire

ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021

03 Nov 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

25 Oct 2021 15:01:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference

22 Oct 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock

21 Oct 2021 08:00:11 By Nasdaq GlobeNewswire

ADMA Biologics Announces Proposed Public Offering of Common Stock

20 Oct 2021 15:01:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference

19 Oct 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.

18 Oct 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021

04 Oct 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021

01 Oct 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference

23 Sep 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for VanRx Aseptic Fill-Finish Machine and Related Operations

08 Sep 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Virtually Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

02 Sep 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN

16 Aug 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments

11 Aug 2021 15:05:01 By Nasdaq GlobeNewswire